Benzalkonium chloride: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{DrugProjectFormSinglePage | {{DrugProjectFormSinglePage | ||
|authorTag={{RB}} | |||
|genericName=Benzalkonium chloride | |||
|aOrAn=a | |aOrAn=a | ||
|drugClass=First Aid Antiseptic | |||
|indicationType=treatment | |indicationType=treatment | ||
| | |indication=minor cuts, scrapes and burns | ||
|adverseReactions=<!--Black Box Warning--> | |adverseReactions=contact allergy | ||
<!--Black Box Warning--> | |||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
<!--Adult Indications and Dosage--> | <!--Adult Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Adult)--> | <!--FDA-Labeled Indications and Dosage (Adult)--> | ||
|fdaLIADAdult====== | |fdaLIADAdult=====Indications==== | ||
* First Aid Antiseptic to help prevent the risk of infection in minor cuts, scrapes and burns | |||
* | |||
====DIRECTIONS==== | |||
clean the affected area | |||
==== | apply a small amount of this product to the area 1-3 times daily | ||
may be covered with a sterile bandage when dry | |||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
|offLabelAdultGuideSupport= | |||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Non–Guideline-Supported Use (Adult)--> | <!--Non–Guideline-Supported Use (Adult)--> | ||
|offLabelAdultNoGuideSupport= | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Pediatric Indications and Dosage--> | <!--Pediatric Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | <!--FDA-Labeled Indications and Dosage (Pediatric)--> | ||
|fdaLIADPed= | |fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Off-Label Use and Dosage (Pediatric)--> | <!--Off-Label Use and Dosage (Pediatric)--> | ||
<!--Guideline-Supported Use (Pediatric)--> | <!--Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedGuideSupport= | |offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Non–Guideline-Supported Use (Pediatric)--> | <!--Non–Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedNoGuideSupport= | |offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
<!--Contraindications--> | |||
|contraindications= | |||
<!--Warnings--> | |||
|warnings=* For external use only. | |||
Do not use | |||
in the eyes | |||
longer than 1 week unless directed by a doctor | |||
Consult a doctor in case of | |||
deep or puncture wounds | |||
animal bites | |||
serious burns | |||
Stop use and ask a doctorif condition persists or gets worse | |||
Keep out of reach of children | |||
If swallowed, get medical help or contact a Poison Control Center right away. | |||
<!--Adverse Reactions--> | <!--Adverse Reactions--> | ||
<!--Clinical Trials Experience--> | <!--Clinical Trials Experience--> | ||
|clinicalTrials= | |clinicalTrials=* contact allergy<ref name="pmid8654070">{{cite journal| author=Effendy I, Maibach HI| title=Surfactants and experimental irritant contact dermatitis. | journal=Contact Dermatitis | year= 1995 | volume= 33 | issue= 4 | pages= 217-25 | pmid=8654070 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8654070 }} </ref> | ||
= | |||
===== | |||
< | |||
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | |postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | ||
Line 244: | Line 123: | ||
<!--Drug Interactions--> | <!--Drug Interactions--> | ||
|drugInteractions= | |drugInteractions= | ||
<!--Use in Specific Populations--> | <!--Use in Specific Populations--> | ||
Line 264: | Line 142: | ||
<!--Administration and Monitoring--> | <!--Administration and Monitoring--> | ||
|administration=* | |administration=* topical | ||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |||
<!--IV Compatibility--> | <!--IV Compatibility--> | ||
Line 275: | Line 151: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|overdose= | |overdose=There is limited information regarding <i>Overdose</i> of {{PAGENAME}} in the drug label. | ||
There is limited information regarding <i> | |||
<!--Pharmacology--> | <!--Pharmacology--> | ||
Line 296: | Line 160: | ||
<!--Structure--> | <!--Structure--> | ||
|structure=* | |structure=* ACTIVE INGREDIENT | ||
Benzalkonium chloride .13% w/v | |||
INACTIVE INGREDIENTS | |||
nonoxynol-9, purified water, sodium bicarbonate | |||
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] | : [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] |
Revision as of 18:53, 13 March 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Benzalkonium chloride is a First Aid Antiseptic that is FDA approved for the treatment of minor cuts, scrapes and burns. Common adverse reactions include contact allergy.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- First Aid Antiseptic to help prevent the risk of infection in minor cuts, scrapes and burns
DIRECTIONS
clean the affected area apply a small amount of this product to the area 1-3 times daily may be covered with a sterile bandage when dry
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Benzalkonium chloride in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Benzalkonium chloride in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Benzalkonium chloride in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Benzalkonium chloride in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Benzalkonium chloride in pediatric patients.
Contraindications
There is limited information regarding Benzalkonium chloride Contraindications in the drug label.
Warnings
- For external use only.
Do not use in the eyes longer than 1 week unless directed by a doctor Consult a doctor in case of deep or puncture wounds animal bites serious burns
Stop use and ask a doctorif condition persists or gets worse
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Clinical Trials Experience
- contact allergy[1]
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Benzalkonium chloride in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Drug Interactions
There is limited information regarding Benzalkonium chloride Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Benzalkonium chloride in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Benzalkonium chloride during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Benzalkonium chloride with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Benzalkonium chloride with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Benzalkonium chloride with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Benzalkonium chloride with respect to specific gender populations.
Race
There is no FDA guidance on the use of Benzalkonium chloride with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Benzalkonium chloride in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Benzalkonium chloride in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Benzalkonium chloride in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Benzalkonium chloride in patients who are immunocompromised.
Administration and Monitoring
Administration
- topical
Monitoring
There is limited information regarding Monitoring of Benzalkonium chloride in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Benzalkonium chloride in the drug label.
Overdosage
There is limited information regarding Overdose of Benzalkonium chloride in the drug label.
Pharmacology
There is limited information regarding Benzalkonium chloride Pharmacology in the drug label.
Mechanism of Action
Structure
- ACTIVE INGREDIENT
Benzalkonium chloride .13% w/v
INACTIVE INGREDIENTS nonoxynol-9, purified water, sodium bicarbonate
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Benzalkonium chloride in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Benzalkonium chloride in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Benzalkonium chloride in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Benzalkonium chloride in the drug label.
How Supplied
Storage
There is limited information regarding Benzalkonium chloride Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Benzalkonium chloride |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Benzalkonium chloride |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Benzalkonium chloride in the drug label.
Precautions with Alcohol
- Alcohol-Benzalkonium chloride interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[2]
Look-Alike Drug Names
- A® — B®[3]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Effendy I, Maibach HI (1995). "Surfactants and experimental irritant contact dermatitis". Contact Dermatitis. 33 (4): 217–25. PMID 8654070.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Page Name=Benzalkonium chloride |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Benzalkonium chloride |Label Name=Benzalkonium chloride11.png
}}
{{#subobject:
|Label Page=Benzalkonium chloride |Label Name=Benzalkonium chloride11.png
}}